HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation-Reference-Cited by-同舟云学术

HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation

Published:2022-11 Issue:9 Volume:46 Page:102024
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Coilly Audrey,Sebagh Mylène,Fougerou-Leurent Claire,Pageaux Georges-Philippe,Leroy Vincent,Radenne Sylvie,Silvain Christine,Lebray Pascal,Houssel-Debry Pauline,Cagnot Carole,Rossignol Emilie,Danjou Hélène,Veislinger Aurélie,Samuel Didier,Duclos-Vallée Jean-Charles,Dumortier Jérôme

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference29 articles.

1. Current status and future of liver transplantation;Merion;Semin Liver Dis,2010

2. Natural history of recurrent hepatitis C;Berenguer;Liver Transpl,2002

3. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients;Berenguer;Hepatology,2002

4. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis;Davies;Hepatology,1991

5. Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation;Zylberberg;Transplantation,1997

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibrosing cholestatic hepatitis as a variant of the course of hepatotropic viruses’ infection;Epidemiology and Infectious Diseases;2024-06-10

2. Fibrosing Cholestatic Hepatitis Masquerading Acute Rejection in Hepatitis C Virus–Positive Donor Liver Graft;ACG Case Reports Journal;2023-05